[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Liver Cancer Market Scenario in 18 Leading Countries Discussed by Black Swan Analysis in Its Research Report Published at MarketPublishers.com

22 Mar 2017 • by Natalie Aster

LONDON – Liver cancer (otherwise termed hepatic cancer) is a type of cancer that begins in the liver cells. The most typical form is hepatocellular carcinoma (HCC) which stems from hepatocytes, the most plentiful cell type in the liver; however, other liver cells can also develop into malignant ones.

Major symptoms and comorbid conditions for liver cancer comprise type 2 diabetes mellitus (DM), hepatitis B, liver cirrhosis, and hepatitis C.

The majority of people with hepatic cancer get it in the environment of chronic liver failure (cirrhosis), which covers the liver with scars and enhances the risk of liver cancer. Conditions causing cirrhosis comprise alcohol dependency, hepatitis C and hepatitis B.

The incidence rate of HCC is gaining traction in the USA owing to surging prevalence of cirrhosis caused by non-alcoholic fatty liver disease (NAFLD) and long-term hepatitis C.

There exists a host of treatment modalities for liver cancer. The treatment cure chosen depends on how much the tumour has metastasised and the overall health of the liver and patients’ general well-being.

Comprehensive study “Liver Cancer Forecast in 18 Major Markets 2017-2027” drawn up by Black Swan Analysis provides deep insights into the present-day  incident population for liver cancer in 18 leading markets, categorised on the basis of gender and 5-year age cohort. The publication sheds light on the causes of the disease, the prevention and risk factors, diagnosis of the illness, disease prognosis and clinical course, and variations by ethnicity and geographic region. The study quantifies a number of major symptoms and comorbid conditions/features related to liver cancer, in tandem with the overall top-line estimated data on incidence rates. The report casts light on the features of liver cancer patients. The study covers the sub-populations within the key disease country-wise over the next ten years.

More in-demand research studies by the publisher are at hand at Black Swan Analysis page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest